This resolution opposes a proposed OMB rule that would replace merit-based scientific review with political oversight and restrict research into diversity, equity, and inclusion, arguing that such changes would undermine U.S. health research and exacerbate health disparities.
Debbie Dingell
Representative
MI-6
This resolution opposes a proposed rule that would grant political appointees oversight of federal research grants and restrict funding for diversity, equity, and inclusion (DEI) initiatives. It argues that these changes would undermine the integrity of the merit-based peer review system and hinder critical research into health disparities. Ultimately, the resolution reaffirms the necessity of inclusive, science-driven research to ensure equitable health outcomes for all Americans.
Proposed Federal Rule Shifts Research Grant Control to Political Appointees and Bans DEI Studies
Imagine if the scientists working on the next breakthrough for heart disease or cancer suddenly had to get their funding approved by a political appointee instead of a panel of experts. This resolution highlights a major shift proposed by the White House Office of Management and Budget (OMB) that would fundamentally change how your tax dollars fund scientific research. Currently, career scientists use a peer-review system to decide which projects are most promising. The new rule would give senior political officials the final word on every single discretionary grant, specifically forbidding them from just deferring to the experts. It also grants agencies the power to pull the plug on active research mid-project if it doesn't align with 'agency priorities,' with no way for the researchers to appeal the decision.
Politics Over Peer Review
The proposed changes move the steering wheel of American innovation from labs to administrative offices. By requiring political sign-offs, the rule could slow down the pace of discovery for everything from new medical devices to local public health initiatives. For a researcher at a state university, this means their multi-year study on heart health could be canceled overnight if a new administration decides the topic isn't a priority. This lack of stability makes it harder for the U.S. to keep top-tier talent, as scientists may look for more predictable funding environments in other countries, potentially costing us the next generation of medical advancements.
Restrictions on Who and What Gets Studied
The rule would also ban federal funding for any research related to diversity, equity, inclusion (DEI), or gender. This isn't just about HR policies; it’s about the science of survival. For decades, most medical research was done on men, leading to treatments that didn't always work for women—like how heart attack symptoms are often missed in women because the 'standard' signs were based on male patients. By cutting off funding for DEI and gender-focused research, we risk going back to a one-size-fits-all approach that ignores the real biological and social differences in how diseases affect Black, Hispanic, or LGBTQ+ patients. When we stop studying why certain groups have worse health outcomes, we end up spending more as a society—roughly $421 billion a year, according to one study—on preventable medical costs and lost productivity.
The Cost of Sharing Knowledge
In a move that feels like a step backward for the digital age, the rule would stop researchers from using grant money to pay for 'article-processing charges.' If you've ever tried to read a medical study only to hit a $40 paywall, you know the frustration. Currently, federal policy requires this research to be free to the public, and grants help cover the fees journals charge to keep those articles open-access. By cutting this funding, the rule makes it harder for doctors in small towns or independent researchers to see the latest data, effectively locking scientific progress behind a subscription fee. Between these costs and new restrictions on working with international scientists, the proposal could create a more isolated and less transparent American scientific community.